nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—SULT2A1—polycystic ovary syndrome	0.617	0.73	CbGaD
Abiraterone—CYP17A1—polycystic ovary syndrome	0.228	0.27	CbGaD
Abiraterone—CYP17A1—ovarian follicle—polycystic ovary syndrome	0.016	0.325	CbGeAlD
Abiraterone—SULT2A1—adrenal cortex—polycystic ovary syndrome	0.00409	0.0827	CbGeAlD
Abiraterone—SULT2A1—adrenal gland—polycystic ovary syndrome	0.00295	0.0597	CbGeAlD
Abiraterone—SULT2A1—female gonad—polycystic ovary syndrome	0.00275	0.0556	CbGeAlD
Abiraterone—SULT2A1—endocrine gland—polycystic ovary syndrome	0.00256	0.0517	CbGeAlD
Abiraterone—CYP3A4—urine—polycystic ovary syndrome	0.00197	0.0398	CbGeAlD
Abiraterone—CYP2D6—urine—polycystic ovary syndrome	0.00194	0.0392	CbGeAlD
Abiraterone—CYP17A1—adrenal cortex—polycystic ovary syndrome	0.00178	0.036	CbGeAlD
Abiraterone—CYP17A1—adrenal gland—polycystic ovary syndrome	0.00128	0.026	CbGeAlD
Abiraterone—CYP17A1—female gonad—polycystic ovary syndrome	0.0012	0.0242	CbGeAlD
Abiraterone—ORM1—endometrium—polycystic ovary syndrome	0.00111	0.0226	CbGeAlD
Abiraterone—CYP17A1—endocrine gland—polycystic ovary syndrome	0.00111	0.0225	CbGeAlD
Abiraterone—Testosterone—CYP11A1—polycystic ovary syndrome	0.000909	0.311	CrCbGaD
Abiraterone—ABCC1—adrenal cortex—polycystic ovary syndrome	0.000904	0.0183	CbGeAlD
Abiraterone—ABCC1—endometrium—polycystic ovary syndrome	0.000807	0.0163	CbGeAlD
Abiraterone—ALB—adrenal gland—polycystic ovary syndrome	0.00079	0.016	CbGeAlD
Abiraterone—ORM1—endocrine gland—polycystic ovary syndrome	0.000782	0.0158	CbGeAlD
Abiraterone—ABCC1—uterus—polycystic ovary syndrome	0.000744	0.015	CbGeAlD
Abiraterone—ABCC1—pituitary gland—polycystic ovary syndrome	0.00073	0.0148	CbGeAlD
Abiraterone—ABCC1—adipose tissue—polycystic ovary syndrome	0.000727	0.0147	CbGeAlD
Abiraterone—CYP2C8—endometrium—polycystic ovary syndrome	0.000687	0.0139	CbGeAlD
Abiraterone—ABCC1—adrenal gland—polycystic ovary syndrome	0.000652	0.0132	CbGeAlD
Abiraterone—Testosterone—SHBG—polycystic ovary syndrome	0.00064	0.219	CrCbGaD
Abiraterone—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000622	0.0126	CbGeAlD
Abiraterone—ABCC1—female gonad—polycystic ovary syndrome	0.000608	0.0123	CbGeAlD
Abiraterone—ABCC1—vagina—polycystic ovary syndrome	0.000605	0.0122	CbGeAlD
Abiraterone—Contusion—Metformin—polycystic ovary syndrome	0.0006	0.0919	CcSEcCtD
Abiraterone—Chest discomfort—Metformin—polycystic ovary syndrome	0.000592	0.0906	CcSEcCtD
Abiraterone—Testosterone—AR—polycystic ovary syndrome	0.000562	0.192	CrCbGaD
Abiraterone—CYP2C8—vagina—polycystic ovary syndrome	0.000515	0.0104	CbGeAlD
Abiraterone—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000482	0.00975	CbGeAlD
Abiraterone—Testosterone—CYP19A1—polycystic ovary syndrome	0.00047	0.161	CrCbGaD
Abiraterone—Testosterone—CYP1A1—polycystic ovary syndrome	0.000346	0.118	CrCbGaD
Abiraterone—CYP2D6—female gonad—polycystic ovary syndrome	0.000345	0.00698	CbGeAlD
Abiraterone—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00034	0.0521	CcSEcCtD
Abiraterone—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000326	0.0066	CbGeAlD
Abiraterone—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000321	0.0065	CbGeAlD
Abiraterone—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000305	0.0468	CcSEcCtD
Abiraterone—Infestation NOS—Metformin—polycystic ovary syndrome	0.000293	0.0449	CcSEcCtD
Abiraterone—Infestation—Metformin—polycystic ovary syndrome	0.000293	0.0449	CcSEcCtD
Abiraterone—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000258	0.0396	CcSEcCtD
Abiraterone—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000244	0.0374	CcSEcCtD
Abiraterone—Angiopathy—Metformin—polycystic ovary syndrome	0.000239	0.0365	CcSEcCtD
Abiraterone—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000237	0.0363	CcSEcCtD
Abiraterone—Hypertension—Metformin—polycystic ovary syndrome	0.000198	0.0303	CcSEcCtD
Abiraterone—Chest pain—Metformin—polycystic ovary syndrome	0.000195	0.0299	CcSEcCtD
Abiraterone—Myalgia—Metformin—polycystic ovary syndrome	0.000195	0.0299	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000194	0.0296	CcSEcCtD
Abiraterone—Discomfort—Metformin—polycystic ovary syndrome	0.000193	0.0295	CcSEcCtD
Abiraterone—Oedema—Metformin—polycystic ovary syndrome	0.000187	0.0286	CcSEcCtD
Abiraterone—Infection—Metformin—polycystic ovary syndrome	0.000186	0.0284	CcSEcCtD
Abiraterone—Skin disorder—Metformin—polycystic ovary syndrome	0.000181	0.0278	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00017	0.0261	CcSEcCtD
Abiraterone—Dyspnoea—Metformin—polycystic ovary syndrome	0.000167	0.0255	CcSEcCtD
Abiraterone—Dyspepsia—Metformin—polycystic ovary syndrome	0.000164	0.0252	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000161	0.0247	CcSEcCtD
Abiraterone—Fatigue—Metformin—polycystic ovary syndrome	0.000161	0.0247	CcSEcCtD
Abiraterone—Constipation—Metformin—polycystic ovary syndrome	0.00016	0.0245	CcSEcCtD
Abiraterone—Asthenia—Metformin—polycystic ovary syndrome	0.000134	0.0205	CcSEcCtD
Abiraterone—Diarrhoea—Metformin—polycystic ovary syndrome	0.000128	0.0196	CcSEcCtD
Abiraterone—Vomiting—Metformin—polycystic ovary syndrome	0.000119	0.0182	CcSEcCtD
Abiraterone—Rash—Metformin—polycystic ovary syndrome	0.000118	0.018	CcSEcCtD
Abiraterone—Dermatitis—Metformin—polycystic ovary syndrome	0.000118	0.018	CcSEcCtD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	3.21e-05	0.000336	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—NAMPT—polycystic ovary syndrome	3.19e-05	0.000334	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—STAR—polycystic ovary syndrome	3.18e-05	0.000333	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.18e-05	0.000332	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.17e-05	0.000332	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NMNAT3—polycystic ovary syndrome	3.17e-05	0.000331	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP11A1—polycystic ovary syndrome	3.15e-05	0.00033	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NMNAT3—polycystic ovary syndrome	3.15e-05	0.00033	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.14e-05	0.000329	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.13e-05	0.000328	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—VEGFA—polycystic ovary syndrome	3.09e-05	0.000324	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—IL6—polycystic ovary syndrome	3.07e-05	0.000321	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	3.03e-05	0.000318	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	3.03e-05	0.000317	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	3.02e-05	0.000316	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	3e-05	0.000314	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	2.99e-05	0.000313	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—AKR1C3—polycystic ovary syndrome	2.98e-05	0.000312	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	2.96e-05	0.000309	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	2.95e-05	0.000309	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—polycystic ovary syndrome	2.95e-05	0.000308	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	2.94e-05	0.000307	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	2.91e-05	0.000305	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SUOX—polycystic ovary syndrome	2.9e-05	0.000303	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—LPCAT2—polycystic ovary syndrome	2.9e-05	0.000303	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SUOX—polycystic ovary syndrome	2.88e-05	0.000301	CbGpPWpGaD
Abiraterone—ALB—Metabolism—LPCAT2—polycystic ovary syndrome	2.88e-05	0.000301	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	2.86e-05	0.000299	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	2.84e-05	0.000298	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—HMMR—polycystic ovary syndrome	2.83e-05	0.000296	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKR1C1—polycystic ovary syndrome	2.78e-05	0.000291	CbGpPWpGaD
Abiraterone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	2.71e-05	0.000284	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—HSD3B1—polycystic ovary syndrome	2.7e-05	0.000283	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ISYNA1—polycystic ovary syndrome	2.69e-05	0.000282	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—POMC—polycystic ovary syndrome	2.68e-05	0.000281	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ISYNA1—polycystic ovary syndrome	2.68e-05	0.00028	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.67e-05	0.00028	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.67e-05	0.000279	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PPARG—polycystic ovary syndrome	2.66e-05	0.000279	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	2.63e-05	0.000275	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—POMC—polycystic ovary syndrome	2.63e-05	0.000275	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	2.62e-05	0.000274	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—INS—polycystic ovary syndrome	2.61e-05	0.000273	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	2.6e-05	0.000272	CbGpPWpGaD
Abiraterone—ABCC1—Disease—FGF18—polycystic ovary syndrome	2.58e-05	0.000271	CbGpPWpGaD
Abiraterone—ABCC1—Disease—RBP4—polycystic ovary syndrome	2.56e-05	0.000268	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—TH—polycystic ovary syndrome	2.54e-05	0.000265	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.53e-05	0.000265	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—IL6—polycystic ovary syndrome	2.5e-05	0.000261	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—SLC2A4—polycystic ovary syndrome	2.47e-05	0.000258	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—LHB—polycystic ovary syndrome	2.46e-05	0.000258	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	2.46e-05	0.000257	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	2.44e-05	0.000256	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—HSD3B2—polycystic ovary syndrome	2.41e-05	0.000252	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	2.4e-05	0.000251	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	2.38e-05	0.000249	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	2.38e-05	0.000249	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.36e-05	0.000247	CbGpPWpGaD
Abiraterone—ABCC1—Disease—GAB1—polycystic ovary syndrome	2.36e-05	0.000247	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AKR1C1—polycystic ovary syndrome	2.33e-05	0.000244	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	2.33e-05	0.000244	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP19A1—polycystic ovary syndrome	2.32e-05	0.000243	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	2.32e-05	0.000243	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NAMPT—polycystic ovary syndrome	2.3e-05	0.000241	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—TEAD2—polycystic ovary syndrome	2.29e-05	0.00024	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKR1C2—polycystic ovary syndrome	2.29e-05	0.00024	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKR1C2—polycystic ovary syndrome	2.28e-05	0.000238	CbGpPWpGaD
Abiraterone—ALB—Metabolism—TEAD2—polycystic ovary syndrome	2.28e-05	0.000238	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	2.21e-05	0.000231	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	2.2e-05	0.000231	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.2e-05	0.00023	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.19e-05	0.000229	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PLAT—polycystic ovary syndrome	2.18e-05	0.000228	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.17e-05	0.000227	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.15e-05	0.000226	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—SULT2A1—polycystic ovary syndrome	2.15e-05	0.000225	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKR1C3—polycystic ovary syndrome	2.14e-05	0.000224	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TNRC6B—polycystic ovary syndrome	2.11e-05	0.000221	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	2.1e-05	0.00022	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	2.1e-05	0.00022	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—RRM2—polycystic ovary syndrome	2.08e-05	0.000218	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GNAS—polycystic ovary syndrome	2.07e-05	0.000217	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.03e-05	0.000212	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—YAP1—polycystic ovary syndrome	2e-05	0.00021	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	1.99e-05	0.000209	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	1.98e-05	0.000208	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—NCOR1—polycystic ovary syndrome	1.97e-05	0.000206	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	1.93e-05	0.000202	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—NAMPT—polycystic ovary syndrome	1.93e-05	0.000201	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	1.92e-05	0.000201	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.91e-05	0.0002	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	1.91e-05	0.0002	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	1.91e-05	0.000199	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP11A1—polycystic ovary syndrome	1.9e-05	0.000199	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.89e-05	0.000198	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.89e-05	0.000197	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	1.88e-05	0.000197	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	1.88e-05	0.000197	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP1A1—polycystic ovary syndrome	1.87e-05	0.000196	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	1.82e-05	0.00019	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	1.81e-05	0.000189	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TCF7L2—polycystic ovary syndrome	1.81e-05	0.000189	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AKR1C3—polycystic ovary syndrome	1.8e-05	0.000188	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SLC2A4—polycystic ovary syndrome	1.78e-05	0.000186	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP17A1—polycystic ovary syndrome	1.77e-05	0.000185	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—MTHFR—polycystic ovary syndrome	1.74e-05	0.000182	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	1.74e-05	0.000182	CbGpPWpGaD
Abiraterone—ALB—Metabolism—STAR—polycystic ovary syndrome	1.73e-05	0.000181	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.72e-05	0.000181	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.72e-05	0.00018	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.71e-05	0.000178	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	1.7e-05	0.000178	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PRL—polycystic ovary syndrome	1.69e-05	0.000177	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—GNAS—polycystic ovary syndrome	1.67e-05	0.000175	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	1.58e-05	0.000165	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	1.55e-05	0.000163	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	1.55e-05	0.000163	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	1.55e-05	0.000162	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HMMR—polycystic ovary syndrome	1.54e-05	0.000161	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—TH—polycystic ovary syndrome	1.53e-05	0.00016	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	1.49e-05	0.000156	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—SLC2A4—polycystic ovary syndrome	1.49e-05	0.000156	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	1.48e-05	0.000154	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	1.47e-05	0.000154	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.46e-05	0.000153	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.45e-05	0.000152	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.45e-05	0.000151	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.45e-05	0.000151	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.44e-05	0.000151	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	1.42e-05	0.000149	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NCOR1—polycystic ovary syndrome	1.42e-05	0.000149	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PPARG—polycystic ovary syndrome	1.41e-05	0.000148	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP19A1—polycystic ovary syndrome	1.4e-05	0.000146	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NRG1—polycystic ovary syndrome	1.39e-05	0.000146	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—POMC—polycystic ovary syndrome	1.39e-05	0.000146	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—INS—polycystic ovary syndrome	1.39e-05	0.000145	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.38e-05	0.000145	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.37e-05	0.000144	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	1.37e-05	0.000144	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	1.35e-05	0.000141	CbGpPWpGaD
Abiraterone—ALB—Metabolism—LHB—polycystic ovary syndrome	1.34e-05	0.00014	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	1.31e-05	0.000138	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	1.31e-05	0.000137	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	1.27e-05	0.000133	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	1.27e-05	0.000133	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	1.27e-05	0.000133	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MTHFR—polycystic ovary syndrome	1.26e-05	0.000131	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GNAS—polycystic ovary syndrome	1.25e-05	0.000131	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.23e-05	0.000129	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.23e-05	0.000129	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	1.21e-05	0.000127	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IRS2—polycystic ovary syndrome	1.19e-05	0.000125	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—NCOR1—polycystic ovary syndrome	1.19e-05	0.000124	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	1.17e-05	0.000123	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	1.17e-05	0.000122	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	1.14e-05	0.000119	CbGpPWpGaD
Abiraterone—ALB—Metabolism—RRM2—polycystic ovary syndrome	1.13e-05	0.000118	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP1A1—polycystic ovary syndrome	1.13e-05	0.000118	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	1.1e-05	0.000116	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	1.09e-05	0.000115	CbGpPWpGaD
Abiraterone—ALB—Metabolism—YAP1—polycystic ovary syndrome	1.09e-05	0.000114	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IGF1—polycystic ovary syndrome	1.08e-05	0.000113	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—AKT2—polycystic ovary syndrome	1.08e-05	0.000113	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	1.08e-05	0.000113	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	1.05e-05	0.00011	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—MTHFR—polycystic ovary syndrome	1.05e-05	0.00011	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.05e-05	0.000109	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NAMPT—polycystic ovary syndrome	1.05e-05	0.000109	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.05e-05	0.000109	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IRS1—polycystic ovary syndrome	1.04e-05	0.000109	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.04e-05	0.000109	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	1.04e-05	0.000109	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	1.03e-05	0.000108	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.03e-05	0.000108	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.03e-05	0.000108	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	1.03e-05	0.000108	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.02e-05	0.000107	CbGpPWpGaD
Abiraterone—ABCC1—Disease—INS—polycystic ovary syndrome	9.98e-06	0.000104	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	9.8e-06	0.000103	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	9.76e-06	0.000102	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	9.75e-06	0.000102	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	9.65e-06	0.000101	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKT2—polycystic ovary syndrome	9.65e-06	0.000101	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	9.62e-06	0.000101	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	9.6e-06	0.0001	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	9.32e-06	9.75e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	9.31e-06	9.75e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SERPINE1—polycystic ovary syndrome	9.17e-06	9.6e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	8.98e-06	9.4e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	8.63e-06	9.03e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PPARG—polycystic ovary syndrome	8.52e-06	8.92e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	8.52e-06	8.92e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—POMC—polycystic ovary syndrome	8.41e-06	8.8e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—INS—polycystic ovary syndrome	8.36e-06	8.75e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—TH—polycystic ovary syndrome	8.35e-06	8.74e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—TH—polycystic ovary syndrome	8.3e-06	8.69e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	8.3e-06	8.69e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	8.12e-06	8.5e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	8.08e-06	8.45e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	8.05e-06	8.42e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	7.92e-06	8.29e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	7.92e-06	8.29e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	7.64e-06	7.99e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	7.59e-06	7.95e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	7.22e-06	7.56e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	7.07e-06	7.4e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	7.06e-06	7.39e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—TH—polycystic ovary syndrome	6.86e-06	7.18e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.84e-06	7.15e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	6.82e-06	7.14e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GNAS—polycystic ovary syndrome	6.78e-06	7.1e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	6.67e-06	6.98e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	6.49e-06	6.8e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NCOR1—polycystic ovary syndrome	6.46e-06	6.76e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	6.29e-06	6.58e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	6.27e-06	6.56e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	6.16e-06	6.44e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	6.12e-06	6.41e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	6.09e-06	6.38e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.87e-06	6.15e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	5.74e-06	6.01e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—MTHFR—polycystic ovary syndrome	5.71e-06	5.97e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.64e-06	5.91e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	5.6e-06	5.86e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.57e-06	5.83e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	5.33e-06	5.58e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.26e-06	5.51e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.18e-06	5.42e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	5.05e-06	5.29e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	4.71e-06	4.93e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	4.65e-06	4.87e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PPARG—polycystic ovary syndrome	4.63e-06	4.84e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	4.59e-06	4.8e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—INS—polycystic ovary syndrome	4.56e-06	4.78e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—POMC—polycystic ovary syndrome	4.56e-06	4.78e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—INS—polycystic ovary syndrome	4.54e-06	4.75e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.48e-06	4.69e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IL6—polycystic ovary syndrome	4.36e-06	4.57e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.36e-06	4.56e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.1e-06	4.29e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	3.82e-06	4e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	3.77e-06	3.94e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—INS—polycystic ovary syndrome	3.75e-06	3.92e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.66e-06	3.83e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.49e-06	3.65e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.3e-06	3.46e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.08e-06	3.22e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.5e-06	2.61e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.46e-06	2.58e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.45e-06	2.56e-05	CbGpPWpGaD
